MedPath

The clinical study to elucidate the effects of Oligonol and the prescription containing Oligonol on the blood flow and its relative body functions.

Phase 2
Conditions
Healthy subjects
Registration Number
JPRN-UMIN000031292
Lead Sponsor
Faculty of Health Care, Teikyo Heisei University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1) person who ingests drug or supplement to improve the blood flow. 2) person who has chronic diseases and ingests the drugs. 3) heavy smoker (over 21/day) 4) heavy drunker (over 20 g of ethanol/day) 5) person who has the potential of allergy against drugs and foods especially, lychee and green tea. 6) person who are pregnant or expected to be pregnant, or lactating during the study. 7) person who cannot stop excess ingesting of the food containing large amount polyphenol such as green tea or brown tea. 8) person who is judged as ineligible by doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood flow
Secondary Outcome Measures
NameTimeMethod
Cold finger, tension in shoulders, swelling of lower limbs
© Copyright 2025. All Rights Reserved by MedPath